Intra-Cellular Therapies ...

NASDAQ: ITCI · Real-Time Price · USD
131.87
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM

Intra-Cellular Therapies Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-74.68M -86.37M -84.3M -110.87M -139.67M -155.12M -184.37M -228.19M -256.26M -297.96M -321.36M -303.5M -284.13M -259.09M -237.37M -232.34M
Depreciation & Amortization
508K 535K 532K 526K 528K 535K 570K 619K 656K 659.83K 623.77K 577.35K 533.36K 512.51K 499.61K 506.32K
Stock-Based Compensation
64.03M 62.56M 59.38M 56.24M 52.83M 49.13M 46.58M 45.35M 43.01M 41.23M 39.01M 35.63M 34.3M 29.69M 27.06M 25.39M
Other Working Capital
-1.33M 23.86M 23M 33.72M 59.41M 37.72M 43.75M 29.18M 11.16M 11.13M 9.07M -3.85M 740.84K -10.93M -19.5M 1.82M
Other Non-Cash Items
49.76M 52.76M 54.61M 29.41M -1.65M -482K -253K 2.88M 538K -613.66K -827.93K -3.93M 178.53K -264.88M -264.87M -264.87M
Deferred Income Tax
n/a -2.54M -4.73M -6.66M -6.66M -4.12M -1.93M -1K -1K -779.78K -2.37M -2.99M -4.08M 261.31M 263.06M 263.64M
Change in Working Capital
-54.1M -30.39M -27.68M -35.23M -29.58M -51.27M -50M -68.06M -58.14M -46.71M -45.16M -20.4M -6.35M -22.14M -27.3M -18.95M
Operating Cash Flow
-73.18M -62.16M -60.91M -98.25M -124.2M -161.33M -189.41M -247.4M -270.19M -304.18M -330.09M -294.63M -259.54M -254.6M -238.91M -226.61M
Capital Expenditures
-322K -750K -322K -269K -269K -240K -89K -212K -778K -807.24K -999.49K -891.74K -325.74K -399.26K -259.92K -244.68K
Cash Acquisitions
n/a -19.9M n/a n/a n/a -30.34M -156.52M -193.87M -193.87M -143.64M -37.35M n/a n/a n/a n/a n/a
Purchase of Investments
-739.68M -586.54M -410.43M -387.86M -415.27M -426.31M -380.84M -40.95M -759.21M -713.09M -657.46M -1.02B -224.57M -422.3M -590.93M -579.31M
Sales Maturities Of Investments
404.85M 449.45M 461.95M 526.31M 521.08M 534.93M 615.65M 218.37M 631.61M 586.77M 488.93M 860.07M 505.24M 475.2M 436.7M 368.51M
Other Investing Acitivies
24M 71.42M 51.52M 138.45M 105.81M 108.62M 234.81M 177.41M -127.59M -126.32M -168.53M -157.07M 280.67M 52.9M -154.23M -210.8M
Investing Cash Flow
-335.15M -137.84M 51.2M 138.18M 105.54M 108.38M 234.72M 177.2M -128.37M -127.13M -169.53M -157.96M 280.34M 52.5M -154.49M -211.04M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
567.51M 564.91M 560.75M 24.16M 17.81M 16.99M 20.07M 16.98M 21.43M 27.16M 21.51M 16M 7.91M 3.64M 6.29M 10.77M
Financial Cash Flow
567.51M 564.91M 560.75M 24.16M 17.81M 16.99M 20.07M 16.98M 455.16M 460.89M 455.82M 451.9M 11.52M 7.24M 385.14M 388.04M
Net Cash Flow
159.18M 364.91M 551.05M 64.09M -848K -35.96M 65.37M -53.22M 56.6M 29.58M -43.8M -684.9K 32.32M -194.86M -8.26M -49.61M
Free Cash Flow
-73.5M -62.91M -61.23M -98.52M -124.47M -161.57M -189.5M -247.62M -270.96M -304.98M -331.09M -295.52M -259.87M -255M -239.17M -226.86M